# Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population

> **NCT05983042** · — · COMPLETED · sponsor: **Riphah International University** · enrollment: 200 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **GENETIC:** Ibuprofen

## Key facts

- **NCT ID:** NCT05983042
- **Lead sponsor:** Riphah International University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983042, "Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05983042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*